Insmed prices $350M follow-on

On Sept. 7, Insmed Inc. (NASDAQ:INSM) raised $350 million through the sale of 12.3 million shares at $28.50 in a bumped-up follow-on underwritten by Goldman Sachs, Leerink, Evercore and Stifel. The price is a 6% premium to Insmed's close of $26.99 on Sept. 5, when the company proposed after trading hours to raise $250 million...